Pharmacy and Poisons Board recalls Flamodip 5mg tablets manufactured by Medico Remedies
Health & Science
By
Esther Nyambura
| Sep 27, 2024
Due to a labeling error, the Pharmacy and Poisons Board (PPB) has issued a recall for Flamodip 5mg tablets, manufactured by Medico Remedies.
In a statement, the Board noted that the product's labeling does not accurately reflect its content.
"The secondary packaging is labeled as Flamodip-5 (Amlodipine), while the first packaging is labeled as Flamodip-5 (Enalapril)," read the statement.
As a result, the PPB has warned the public against the use, sale, and distribution of the product.
Flamodip-5 (Amlodipine) is typically used alone or with other medications to treat high blood pressure in adults and children aged six years and older.
READ MORE
How Kenyans can get jobs in Germany under new pact
Race to pick second CBK deputy intensifies as six shortlisted
Kakuzi announces Sh100 million investment plan
Government banks on incentives to attract investment in tourism sector, Miano
Intrigues that led to ouster of maritime agency boss
How the new building code will tame rogue developers
KQ, Jambojet flights disrupted after fuel supply glitch
Cost of State emergency loans spikes on higher CBK base rate
Tax hikes and new rules to push agriculture to the brink
Bank ordered to pay construction company from Somalia Embassy accounts
It is also prescribed to manage certain types of angina (chest pain) and coronary artery disease, which involves the narrowing of blood vessels supplying blood to the heart.
On the other hand, Enalapril is used to treat high blood pressure and heart failure (the weakening of heart function).
Amlodipine works by relaxing blood vessels, allowing blood to flow more easily, thereby reducing blood pressure while Enalapril relaxes and widens blood vessels, helping the heart pump blood more effectively, which in turn lowers elevated blood pressure.
However, the two contain different active ingredients: Amlodipine, a calcium channel blocker, and Enalapril, an angiotensin-converting enzyme (ACE) inhibitor.
- Postal Corporation hikes costs for digital addresses by 2000pc
- Restless youth raise pressure despite Ruto's concessions
- Why Ichung'wa is wrong on Gen Z protests